MHMuad Abdi Hassan

Muad Abdi Hassan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Muad Abdi Hassan has a total of 42 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A case report of sanguisis streptococcal sepsis associated with the orthodontic appliance in a young male with aortic valve disease

    by Bassem Al Hariri, Yussuf Abdi Hassan, Abdelkarim Mohamed, Muad Abdi Hassan

    Objectives: The risk of endocarditis is caused by Streptococcus viridans, which is found in the mouth and can cause dental issues. Men over 45 are at higher risk of endocarditis, and orthodontic appliances can disrupt mouth bacteria, increasing the risk of endocarditis and oral streptococci. Good oral hygiene and checkups can prevent complications, and patients in orthodontic treatment should be monitored for heart conditions and educated on oral hygiene. Case presentation: A 31-year-old male with known aortic valve disease was admitted for infective endocarditis and was treated with intravenous ceftriaxone. Conclusions: Fixed orthodontic appliances increase the risk of endocarditis and oral Streptococci, but patients can reduce these risks by maintaining oral hygiene and adhering to home oral hygiene routines; regular professional dental cleanings can also help maintain oral health during fixed orthodontics.

  • Open Access

    Cholestatic Hepatic Injury Induced by Carbimazole: A Case Report and a Thorough Literature Review

    by Bassem Al Hariri, Mohammed Omer Elbadawi Elhassan, Hadil Altaj Altrify Alsidig, Muad Abdi Hassan, Abdalrahman Mohammed Mostafa, Memon Noor Illahi

    Carbimazole, a thionamide derivative, is widely used for hyperthyroidism but carries a rare risk of hepatotoxicity, including cholestatic injury. A 42‐year‐old man developed severe cholestatic jaundice 4 weeks after carbimazole initiation. Laboratory findings showed marked hyperbilirubinemia (peak: 650 μmol/L) with elevated ALP (366 U/L). Viral, autoimmune, and biliary causes were excluded. Liver biopsy confirmed cholestasis. Carbimazole was discontinued, corticosteroids initiated, and radioiodine therapy planned. Bilirubin levels gradually improved over 8 weeks. Carbimazole‐induced cholestasis, though rare, necessitates prompt recognition and alternative hyperthyroidism management. Routine liver monitoring is crucial.


  • Open Access

    Efficacy and adverse effects of remdesivir in patients with COVID-19 pneumonia: a retrospective study

    by Bassem Al Hariri, Muad Abdi Hassan, Manish Barman, Vajeeha Haider, Rawan S. Mohamed, Ahmad Alharafsheh, Aram Salehi, Memon Noor Illahi, Mohamed Gaafar Mohamedali

    Background: Remdesivir is an antiviral medication approved by the US FDA to treat COVID-19 in hospitalized patients. However, it has unknown adverse effects and has shown deleterious impacts on several organ systems in randomized controlled trials. This study aims to describe the safety and efficacy of Remdesivir administration in a cohort of 586 patients admitted to a tertiary hospital in Qatar for COVID-19-related reasons. Methods: A retrospective study of 586 patients admitted with a diagnosis of COVID-19 and treated with Remdesivir were compared to 200 patients with COVID-19 who did not receive Remdesivir. Results: The rate of mechanical ventilation admission to the intensive care unit was comparable across the two groups (2.35% vs. 2%, p=0.75). Death rates were similar between the two groups (0.02% vs. 0.03%, p=0.43). There was a mean reduction in heart rate within the first three days of antiviral therapy. Negligible variations in serum AST, ALT, ALP, and eGFR levels were detected. Remdesivir-treated patients had a significantly shorter hospital stay. Conclusions: When using Remdesivir in COVID-19 patients, it's important to be cautious by evaluating baseline parameters and avoiding concurrent use of drugs that could affect the heart, kidneys, or liver.


  • Open Access

    Kounis Syndrome Type 2 due to Ingestion of a Fish Meal: A Case Report

    by Bassem Al Hariri, Obada Adel Alsakaji, Abdelkarim Mohamed, Muad Abdi Hassan

    Kounis syndrome is a type of acute coronary syndrome that occurs when a chemical mediator produced by mast cell activation leads to coronary artery vasospasm. This can happen due to anaphylaxis, anaphylactoid reactions, allergies, or hypersensitivities. There are three variants of Kounis syndrome, including vasospastic allergic angina, an atheromatous disease with plaque eruption, and stent thrombosis. In this case, the patient developed type 2 Kounis syndrome after consuming a fish meal, which caused him to present with a non‐ST elevation myocardial infarction (NSTEMI) at our hospital.


  • Open Access

    Periodic Paralysis: A Case Series with a Literature Review

    by Bassem Al Hariri, Muad Abdi Hassan, Muhammad Sharif, Obada Adel Alsakaji, Yussuf Abdi Hassan, Muayad Kasim Khalid

    Introduction: Periodic paralysis is a condition that causes recurrent episodes of flaccid paralysis, and it can be primary or secondary. Hypokalemic periodic paralysis is the most common type of primary periodic paralysis, and it is inherited through autosomal dominant gene transmission. Males are affected three times more often than females, and the paralysis attacks usually occur at night after a period of vigorous exercise. It is crucial to exclude other diagnostic entities based on the nature of presentation, physical examination, and paraclinical studies. Thyrotoxic periodic paralysis is more prevalent in Asian or Hispanic males with thyrotoxicosis, where up to 10% of thyrotoxic patients may experience periodic paralysis. Case Presentations: Here, we present 6 cases of patients who came to our care with varying degrees of muscle weakness, each showing interesting and diverse laboratory results. Conclusion: In patient assessment, it is crucial to consider social and family history. Even without this information, awareness of potential diagnoses is vital. The cause should be carefully considered for possible simple treatments. Failing to recognize and address this condition promptly could lead to severe outcomes. Timely identification and intervention are essential for effective disease management and patient welfare.


  • Open Access

    An idiopathic severe macroglossia in a young adult patient: a rare case

    by Bassem Al Hariri, Muad Abdi Hassan, Muhammad Sharif, Rawan S Mohamed, Hadil Altaj Altrify Alsidig, Hind Altag Alteraify Alsiddig, Memon Noor Illahi

    Macroglossia, an uncommon anatomical anomaly, can manifest as either congenital or acquired. The size of the tongue undergoes variations with age, peaking at 8 years and reaching full maturity at 18 years. Congenital macroglossia stems from diverse conditions, such as muscular hypertrophy, hemangioma, lymphangioma, Down syndrome, and others. Acquired macroglossia can result from malignancies, endocrine and metabolic disorders, chronic infectious diseases, and head and neck infections, among other factors. Additionally, extended-prone surgery can lead to its development. The incidence of macroglossia is likely underreported. This presentation is rare with only six reported cases in the literature.


  • Open Access

    Brucellosis an Unusual presentation as isolated septic mono-arthritis of the knee joint: A case report

    by Muad Abdi Hassan, Fatima Noor, Aram Salehi, Bassem Al Hariri


  • Open Access

    Spontaneous hemothorax caused by rivaroxaban treatment for pulmonary embolism: A case report

    by Bassem Al Hariri, Ahmad Taher Alharafsheh, Muad Abdi Hassan, Abdulqadir J. Nashwan, Mohamed Gaafar Mohamedali, Hatem Mabrouk Abusriwil

    Key Clinical Message: Hemothorax is a rare and potentially fatal condition characterized by pleural effusion containing over 50% of the patient's hematocrit. A massive hemothorax involves blood loss exceeding 1.5 L. Common causes include chest trauma, invasive thoracic procedures, anticoagulant medications, vascular anomalies, malignancies, and hematologic abnormalities. Spontaneous hemothorax may be seen in conjunction with pulmonary infarction and spontaneous pneumothorax. Anticoagulation is a key therapeutic strategy for certain thromboembolic events, such as pulmonary embolism. Historically, these events were treated with vitamin K antagonists (VKAs), which have demonstrated variable plasma concentrations and an increased risk of hemorrhage. With the advent of direct oral anticoagulants (DOACs), treatment has become as effective as VKAs while significantly reducing the risk of hemorrhage. However, some researchers have speculated that hemorrhagic complications in certain cases could be worse with DOACs than with VKAs. In the case presented here, we identified a genuine association between the use of rivaroxaban and spontaneous hemothorax following the initiation of treatment for pulmonary embolism.


  • Open Access

    A rare case of myxoma presenting as a scrotal lump

    by Muad Abdi Hassan, Jouhar J. Kolleri, Noor Al-Nassr, Tala Kanaan, Khaled A. Murshed, Nabil Sherif Mahmood